Efficacy of Montelukast as Added Therapy in Patients with Chronic Idiopathic Urticaria
Inflammation & Allergy - Drug Targets, 04/30/2012
Khan S et al. – Almost half of the patients with chronic urticaria responded to montelukast and combined anti–H1 and anti–H2 therapy. The authors were unable to identify any clinical features or laboratory markers that were associated with a response to montelukast.